APA (7th ed.) Citation

Li S, Hui Y, Yuan J, Zhang Z, Li X, Fang N, . . . Hou Q. (2021). Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in vivo and in vitro. Dove Medical Press.

Chicago Style (17th ed.) Citation

Li S, Hui Y, Yuan J, Zhang Z, Li X, Fang N, Lin M, and Hou Q. Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in Vivo and in Vitro. Dove Medical Press, 2021.

MLA (9th ed.) Citation

Li S, et al. Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma–COPD Overlap in Vivo and in Vitro. Dove Medical Press, 2021.